This funding has provided support to undergraduate, graduate, and medical students, postdoctoral and early career researchers, young doctors, academic scientists, and clinician-scientists. Each dollar, and each person, works towards the goal of improving the lives of people with psoriasis and psoriatic arthritis (PsA).
Capacity of Electrophilic Fatty Acids to Accumulate in the Skin - Alicia Mathers, Ph.D.
Longitudinal Relationships Among Sleep Health, Systemic Inflammation, and Disease Activity in Psoriatic Arthritis - Lourdes Perez Chada, M.D.
Immune Cell Contributions to Inflammatory Arthritis - Nicole L. Ward, Ph.D.
Linkage Analysis of Familial Psoriasis - James Elder, M.D., Ph.D.
Total body PET/CT Imaging Biomarkers for Diagnosing and Quantifying Inflammatory Burden of Psoriatic Arthritis - Siba Raychaudhuri, M.D.
Exploring the Impact of Immune-Mediated Lipolysis on the Pathophysiology of Psoriasis - Monika Bambouskova, Ph.D.
Transcriptome-Wide Study of Adalimumab Response in Psoriatic Arthritis - James Bluett, Ph.D.
Targeting Neutrophil Functions as a Novel Model of Psoriasis Immunotherapy - Zvi Granot, Ph.D.
The Demographics and Genetics of Psoriasis in Kenya - Wilson Liao, M.D.
Unraveling AhR Modulation for Advancements in Psoriasis Therapeutics - Stefano Motta, Ph.D.
Interrogating T-Cell Mediated Mechanisms Underlying the Development of Atherosclerosis in Patients With Psoriasis - Patricia Nguyen, M.D.
GLUT1 Inhibition by Lipid Nanoparticle (LNP) siRNA and Phloretin as Novel Treatments for Psoriasis - Richard Wang, M.D., Ph.D.
Using Peer Mentors to Increase the Racial/Ethnic Diversity of Psoriatic Disease Research Participants - Junko Takeshita, M.D., Ph.D., MSCE
Personalized Medicine in Psoriatic Arthritis: The Role of Obesity - Paras Karmacharya, M.D.
Engineered Immunological Niche for Monitoring Psoriatic Arthritis - Aaron Morris, Ph.D.
Sex Differences in Cellular Immune Profiles in Psoriatic Arthritis - Steven Dang, B.Sc.
Transcriptional Regulation of Synovial Tissue Resident Memory CD8 T Cells - Paul Hsu, M.D., Ph.D.
Development of CD8+ Tissue Resident Memory T Cells in Psoriatic Arthritis - Serena Melgrati, Ph.D.
The Role of Group A Streptococcus-Derived, HLA-C*06:02-Restricted Antigens in Psoriasis - Runqiu Song, M.Bio.H.Sc.
Prediction of Psoriatic Arthritis in New Onset Psoriasis Using Data from the Stockholm Psoriasis Cohort (SPC-PSA) - Axel Svedbom, Ph.D.
Depression in Psoriasis: Genetic Background, Metabolic, and Inflammatory Factors - Mona Stahle, M.D.
Prevention of Cardiovascular Disease and Mortality in Patients with Psoriasis or Psoriatic Arthritis (CP3) - Joel Gelfand, M.D., MSCE
Investigating Cellular and Molecular-Based Biomarkers of Disease Progression in Psoriatic Arthritis - Jose Scher, M.D., Sergei Koralov, Ph.D., Wilson Liao, M.D.
Multi-omic Diagnostic Test for Psoriatic Arthritis in Psoriasis Patients - Vinod Chandran, MBBS, M.D., D.M., Ph.D.
Patient Characteristics and Comparison of Definitions of Difficult-To-Treat Psoriatic Arthritis in a Longitudinal Cohort - Matthew Anacleto-Dabarno, M.D., C.M.
An Integrated Single-Cell and Spatial-Transcriptomic Analysis of Synovial Inflammation in Psoriatic Arthritis - Ryan Malcolm Hum, MBChB, MRCP(UK)
Development of a Multibiologic Failure Database for Psoriasis - Allison Kranyak, M.D.
The Price of Health: Out-of-Pocket Expenses and Their Effect on Treatment Adherence and Discontinuation in Psoriatic Disease - Alyssa Roberts, B.S.
Characterization of Epidermal Lipid Expression in a Diverse Sample to Identify Diagnostic Biomarkers in Psoriasis - Reneé Haughton, M.D.
Degrading CARD14 to Treat Psoriasis - Anne Bowcock, Ph.D.
Identifying Metabolomic Markers of Disease Activity in Psoriatic Arthritis - Vinod Chandran, D.M., Ph.D.
Proteomics Profiling for Personalized Psoriasis Treatment - Bingjian Feng, Ph.D.
Role of IL-36 in Pustular Psoriasis and Its Female Skewing - Mrinal Sarkar, Ph.D.
Th9-Endothelial Crosstalk Promotes Cardiovascular Disease in Patients with Psoriasis - Daniella Schwartz, M.D.
With your gift we can fund even more research to get better treatment and diagnostic options and someday, a cure.
The NPF has awarded over $30 million in research funding in recent years, with immeasurable impact on our community.
Learn more about available NPF grant mechanisms and other funding opportunities.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.